BXQ-350 Neuroprotective Outcomes in Chemotherapy Induced Peripheral Neuropathy (CIPN) Patients

from Bexionpharma.com During Bexion’s Phase 1 study of BXQ-350 in adult patients with advanced solid tumors, a patient self-reported complete resolution of long term, persistent Chemotherapy Induced Peripheral Neuropathy (CIPN).  Due to this unexpected reporting, Bexion elected to explore this finding further by reviewing data from a cohort of patients…

Continue reading

Bexion Pharmaceuticals, Inc. to Present at the 2022 International Symposium on Pediatric Neuro-Oncology (IPSNO) Annual Conference

FOR IMMEDIATE RELEASE [Covington, KY—June 13, 2022 download the pdf Bexion Pharmaceuticals, Inc., a mid-stage clinical biopharmaceutical company, announced today that two abstracts submitted for an in-person session at the IPSNO annual meeting to be held in Hamburg, Germany, June 12-15, 2022 has been chosen for poster presentation. ISPNO is the largest…

Continue reading

If No One Knows, No One Cares: #Moonshot4Kids Delivers Urgent Message to President Biden at the White House

“…This is the reality for childhood cancer; we all assume–even the President!–that if we invest in something it will of course trickle down to our children. This is the wake up call of #Moonshot4Kids: medical research investment into cures for children is one area where our priorities as Americans are completely upside-down. You don’t know it until it directly affects you. We spend more dollars on potato chips annually than our government invests into childhood cancer…”

Continue reading

Superpowers Unite: The ChadTough Defeat DIPG Foundation

Childhood Cancer Talk Radio Presents Tammi Carr and Jenny Mosier Today’s show features interviews with Tammi Carr and Jenny Mosier, leaders of their respective foundations, Chadtough, in Ann Arbor Michigan and Michael Mosier Defeat DIPG Foundation in Bethesda Maryland, recently merged into the ChadTough Defeat DIPG Foundation. Each foundation leader…

Continue reading

RUBIO APPLAUDS PASSAGE OF RESOLUTION TO DESIGNATE MAY 17 AS DIPG PEDIATRIC BRAIN CANCER AWARENESS DAY 

For Immediate Release Contact: Dan Holler, 202-224-3041 May 25, 2021 Washington, D.C. — U.S. Senator Marco Rubio (R-FL) applauded the passage of his resolution to designate May 17 as DIPG Pediatric Brian Cancer Awareness Day (S.Res.231), which raises awareness of, and encourages research on Diffuse Intrinsic Pontine Glioma (DIPG) tumors and other pediatric…

Continue reading

All In To Win Foundation with Christina Wascher

Christina Wascher, a long-time childhood cancer advocate, is the President and founder of the All-In-to-Win Foundation based in Miami Florida since 2013. Christina has been a philanthropist and an entrepreneur in US and European project developments for Claridon International since 1982, specializing in start-up projects and bringing them to completion.…

Continue reading

Today on CCTR: Bexion Pharmaceuticals Introduces Phase II Clinical Trial for DIPG/DMG with BXQ-350

      Today on Childhood Cancer Talk Radio on TogiNet.com at 4pm EST,  Founder and CEO of Bexion Pharmaceuticals Dr. Ray Takigiku and Medical Affairs Consultant and Leader of the phase II clinical trial for DIPG/DMG at Cincinnati Children’s Hospital, Dr. Richard Curry.  Both scientists provide insight into the…

Continue reading